WP
Woodline Partners Portfolio holdings
AUM
$18.9B
1-Year Return
23.37%
This Quarter Return
+21.33%
1 Year Return
+23.37%
3 Year Return
+125.78%
5 Year Return
+185.63%
10 Year Return
–
AUM
$3.77B
AUM Growth
+$720M
(+24%)
Cap. Flow
+$382M
Cap. Flow
% of AUM
10.12%
Top 10 Holdings %
Top 10 Hldgs %
22.38%
Holding
294
New
116
Increased
45
Reduced
52
Closed
77
Top Buys
| 1 |
Amgen
AMGN
|
$115M |
| 2 |
Alphabet (Google) Class A
GOOGL
|
$97.8M |
| 3 |
NXP Semiconductors
NXPI
|
$61.6M |
| 4 |
Eli Lilly
LLY
|
$57.7M |
| 5 |
Qorvo
QRVO
|
$53.9M |
Top Sells
| 1 |
Microchip Technology
MCHP
|
$72.6M |
| 2 |
Bristol-Myers Squibb
BMY
|
$66.5M |
| 3 |
Amazon
AMZN
|
$65.6M |
| 4 |
HZNP
Horizon Therapeutics Public Limited Company Ordinary Shares
HZNP
|
$57.9M |
| 5 |
ALXN
Alexion Pharmaceuticals Inc
ALXN
|
$53.4M |
Sector Composition
| 1 | Healthcare | 42.9% |
| 2 | Technology | 32.83% |
| 3 | Communication Services | 8.98% |
| 4 | Financials | 3.92% |
| 5 | Consumer Discretionary | 3.14% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
151
Immatics
IMTX
$695M
| $5.52M | 0.15% |
511,256
+324,665
| +174% | +$3.5M |
|
152
C4 Therapeutics
CCCC
$190M
| $5.51M | 0.15% |
+166,323
| New | +$5.51M |
|
153
Exelixis
EXEL
$10.1B
| $5.48M | 0.15% |
272,800
-1,039,087
| -79% | -$20.9M |
|
154
Nurix Therapeutics
NRIX
$697M
| $5.3M | 0.14% |
161,211
+17,124
| +12% | +$563K |
|
|
CHMA
155
DELISTED
Chiasma, Inc. Common Stock
CHMA
| $5.29M | 0.14% |
1,216,512
-111,745
| -8% | -$486K |
|
156
Walt Disney
DIS
$214B
| $5.21M | 0.14% |
+28,769
| New | +$5.21M |
|
157
Orchestra BioMed
OBIO
$148M
| $5.17M | 0.14% |
403,699
+3,699
| +0.9% | +$47.4K |
|
158
American Well
AMWL
$109M
| $5.16M | 0.14% |
10,176
-407
| -4% | -$206K |
|
|
MTEM
159
DELISTED
Molecular Templates, Inc.
MTEM
| $4.86M | 0.13% |
34,511
-39,543
| -53% | -$5.57M |
|
160
GoodRx Holdings
GDRX
$1.49B
| $4.62M | 0.12% |
114,520
+52,020
| +83% | +$2.1M |
|
|
FSDC
161
DELISTED
FS Development Corp. Class A Common Stock
FSDC
| $4.55M | 0.12% |
413,332
| – | – |
|
162
Interparfums
IPAR
$3.68B
| $4.43M | 0.12% |
+73,273
| New | +$4.43M |
|
163
4D Molecular Therapeutics
FDMT
$309M
| $4.29M | 0.11% |
+103,453
| New | +$4.29M |
|
|
MOTV.U
164
DELISTED
Motive Capital Corp Units, each consisting of one Class A ordinary share, and one-third of one redee
MOTV.U
| $4.22M | 0.11% |
+400,000
| New | +$4.22M |
|
|
APTO
165
DELISTED
Aptose Biosciences, Inc.
APTO
| $4.21M | 0.11% |
2,138
-1,490
| -41% | -$2.94M |
|
166
Envista
NVST
$3.45B
| $4.18M | 0.11% |
123,855
-33,766
| -21% | -$1.14M |
|
167
AT&T
T
$212B
| $4.05M | 0.11% |
+186,602
| New | +$4.05M |
|
168
HP
HPQ
$27B
| $4.05M | 0.11% |
+164,698
| New | +$4.05M |
|
169
Sutro Biopharma
STRO
$86.5M
| $3.96M | 0.1% |
+182,179
| New | +$3.96M |
|
170
Coty
COTY
$3.82B
| $3.94M | 0.1% |
+561,433
| New | +$3.94M |
|
171
e.l.f. Beauty
ELF
$7.59B
| $3.7M | 0.1% |
+147,026
| New | +$3.7M |
|
172
Certara
CERT
$1.7B
| $3.6M | 0.1% |
+106,665
| New | +$3.6M |
|
173
Lufax Holding
LU
$2.57B
| $3.55M | 0.09% |
+62,500
| New | +$3.55M |
|
|
MKTWW
174
DELISTED
MarketWise, Inc. Warrant
MKTWW
| $3.43M | 0.09% |
2,004,385
| – | – |
|
|
YQ
175
17 Education & Technology Group
YQ
$21.6M
| $3.39M | 0.09% |
+13,232
| New | +$3.39M |
|